The mainstream media is obsessed with a tired narrative: that the "transactional" approach of US foreign policy under certain administrations is a death sentence for African health systems. They wring their hands over the potential scaling back of PEPFAR or the strings attached to bilateral trade agreements. They call it "heartless." I call it a long-overdue reality check.
The critics are missing the forest for the trees. The real threat to African health isn't a reduction in American largesse; it’s the permanent state of dependency that "traditional" aid creates. We have spent decades pouring billions into top-down, donor-driven programs that treat African nations like charity cases rather than sovereign markets. If you want to talk about "deals," let’s talk about the raw deal Africa gets when it is forced to rely on the whims of a fickle US Congress for its basic medical supplies.
The Myth of the Benevolent Donor
For years, the consensus has been that more aid equals better outcomes. It sounds logical. It’s also wrong. When a foreign government provides $5 billion for HIV/AIDS medication, they aren't just giving medicine; they are effectively dismantling the local incentive to build a pharmaceutical manufacturing base. Why would a Kenyan entrepreneur invest in a drug plant when Uncle Sam is giving the product away for free?
This isn't theory. I have seen mid-sized African pharma firms fold because they couldn't compete with "free." We are subsidizing American pharmaceutical giants to ship products across the ocean while keeping African industry in a state of arrested development.
The critics of a "deal-based" approach hate it because it requires transparency. A deal has terms. A deal has an ROI. A deal assumes both parties are adults. Traditional aid, conversely, is a soft-power tool wrapped in a humanitarian ribbon. It keeps African health ministries in a cycle of begging, reporting to NGOs in D.C., and praying the next election doesn't wipe out their budget.
The Efficiency of the Transaction
Let’s dismantle the "People Also Ask" obsession with whether private-sector involvement hurts the poor. The premise is flawed. You know what hurts the poor? A government clinic with no electricity and a "donated" MRI machine that no one knows how to fix.
When we shift from "aid" to "deals," we shift the focus to infrastructure and sustainability. If a US administration demands that health investments are tied to trade access or security cooperation, it forces a conversation about value. It moves healthcare from the "charity" column—which is always the first to be cut during a recession—to the "strategic interest" column.
Why the "Transactional" Label is a Badge of Honor
- Accountability: In a "deal," if the results aren't met, the funding stops. In "aid," if the results aren't met, we usually just send more money to "fix the capacity issue."
- Local Ownership: Transactional diplomacy forces African leaders to negotiate. It puts them in the driver’s seat. They have to decide what they are willing to trade for health outcomes. This is the definition of sovereignty.
- Market Creation: Deals often involve public-private partnerships. This brings in groups like GE Healthcare or Siemens, who don't just drop off boxes; they build service centers because they have a profit motive to keep the machines running.
The PEPFAR Paradox
Everyone points to the President's Emergency Plan for AIDS Relief (PEPFAR) as the gold standard. It has saved millions of lives. That is an empirical fact. But it has also created a parallel health system. In many sub-Saharan countries, the "PEPFAR system" is better funded and more efficient than the national health system.
This is a disaster in the making. We have created a "health bubble" that exists outside the local government’s control. When critics scream that a more "America First" policy will "destabilize" these systems, they are admitting that these systems are already unstable. They are built on sand.
Instead of crying about "deals," we should be demanding them. We need deals that trade US technology for African regulatory reform. We need deals that prioritize local vaccine production over shipping frozen vials from Maryland.
The Cost of the Status Quo
The "lazy consensus" says that we must protect the status quo at all costs. But look at the data. Despite trillions in aid over sixty years, the "brain drain" of African doctors to the West is accelerating. Why? Because the aid-funded environment is a dead end for professional growth. It’s a series of vertical silos managed by consultants in Geneva and New York.
A transactional approach, which focuses on business-to-business ties, actually creates a reason for a Nigerian surgeon to stay in Lagos. If there is a "deal" to build a world-class cardiac center that operates on a sustainable revenue model, that doctor has a future. If there is only a "program" to distribute generic heart meds, that doctor is moving to London.
The Uncomfortable Truth About "Strings Attached"
Critics moan that modern US policy uses health as a "bargaining chip." Newsflash: Every country uses every tool at its disposal for its national interest. At least the "transactional" crowd is honest about it.
The previous model used health as a tool for ideological compliance. If you wanted the funding, you had to adopt Western-centric views on everything from social policy to economic structure. Is that not "strings"?
A deal-based approach says: "We want access to your rare earth minerals, and in exchange, we will provide the capital and tech to build a regional biotech hub." That is a transparent exchange. It’s honest. It’s something a local politician can explain to their constituents without sounding like a colonial administrator's assistant.
The Risks of This Path
I am not saying this is easy. The downside of a transactional approach is that it requires high-level competence from African negotiators. If a government is corrupt or inept, they will get fleeced. But the solution to potential fleecing isn't to return to the breast of the donor state. The solution is to get better at the table.
We are seeing this happen already. Nations like Rwanda and Ghana are increasingly pushing back on "gift" models in favor of investment models. They are moving toward a future where "health" is an industry, not a line item in a foreign budget.
Stop Asking for Charity
The most patronizing thing you can do for a continent of 1.4 billion people is to assume they can't survive without a specific line item in the US federal budget. The "outcry" over Trump’s health "deals" in Africa is largely driven by the NGO industrial complex—the thousands of Westerners whose high-paying jobs depend on the "aid" cycle continuing forever.
They don't want the system to change because they are the system.
If you actually care about African health, you should be cheering for the end of the aid era. You should be demanding more deals, more trade, and more cold-blooded business transactions.
Stop looking for a savior in Washington. Start looking for a partner in the boardroom. The era of the "patient" continent is over; the era of the "partner" continent is just beginning, and it won't be built on a foundation of "free" handouts.
The "deals" aren't the problem. They are the only way out.
